Markus Angerer
YOU?
Author Swipe
View article: Robotic Retroperitoneal Lymph Node Dissection for Testicular Cancer—First Experience and Learning Curve of a Single Surgeon
Robotic Retroperitoneal Lymph Node Dissection for Testicular Cancer—First Experience and Learning Curve of a Single Surgeon Open
Background/Objectives: Retroperitoneal lymph node dissection (RPLND) plays a crucial role in the staging and treatment of testicular cancer and is often mandatory. RPLND is associated with a high risk of morbidity. The use of minimally inv…
View article: Feasibility and Oncological Safety of Robotic Retroperitoneal Lymph Node Dissection in Patients with Testicular Cancer—Single-Center Experience
Feasibility and Oncological Safety of Robotic Retroperitoneal Lymph Node Dissection in Patients with Testicular Cancer—Single-Center Experience Open
Background/Purpose: Retroperitoneal lymph node dissection (RPLND) plays a crucial role in the surgical management of testicular cancer. However, RPLND is associated with a high risk of morbidity. Currently, open RPLND (O-RPLND) is consider…
View article: Robotic Retroperitoneal Lymph Node Dissection for Testicular Cancer—First Experience and Learning Curve of a Single Surgeon
Robotic Retroperitoneal Lymph Node Dissection for Testicular Cancer—First Experience and Learning Curve of a Single Surgeon Open
Introduction: Retroperitoneal lymph node dissection (RPLND) plays a crucial role in the staging and treatment of testicular cancer, and is often mandatory. RPLND is associated with a high risk of morbidity. The use of minimally invasive te…
View article: Serum Levels of MicroRNA-371a-3p for Predicting the Histology of Postchemotherapy Residual Masses of Germ Cell Tumours
Serum Levels of MicroRNA-371a-3p for Predicting the Histology of Postchemotherapy Residual Masses of Germ Cell Tumours Open
The microRNA-371a-3p (M371) test can identify about two-thirds of patients with viable cancer in residual metastatic masses following chemotherapy for germ cell tumours. Only masses with high percentages of viable cancer cells can be ident…
View article: Unilateral, Small, Benign, Late-Onset, Large-Cell Calcifying Sertoli Cell Tumor: A Case Report
Unilateral, Small, Benign, Late-Onset, Large-Cell Calcifying Sertoli Cell Tumor: A Case Report Open
Large-cell calcifying Sertoli cell tumor (LCCST) is a rare, testicular sex cord, gonadal stromal tumor that belongs to the histological subgroup of Sertoli cell tumors. LCCSTs may involve malignant potential. However, metastasis is a rare …
View article: Familial Testicular Germ Cell Tumor in Two Brothers With Emery Dreifuss Muscular Dystrophy Caused by an FHL-1 Mutation: A Case Report
Familial Testicular Germ Cell Tumor in Two Brothers With Emery Dreifuss Muscular Dystrophy Caused by an FHL-1 Mutation: A Case Report Open
Testicular germ cell tumor (GCT) is a rare disease, accounting for no more than 1.5% of all neoplasms in males, but represents the most common tumors in adolescents and young men in Western countries. There is also consensus about the invo…
View article: Impact of Sarcopenia on Functional and Oncological Outcomes After Radical Prostatectomy
Impact of Sarcopenia on Functional and Oncological Outcomes After Radical Prostatectomy Open
Introduction and Objectives: Knowledge about the significance of sarcopenia (muscle loss) in prostate cancer (PCa) patients is limited. The aim of this study was to determine the influence of skeletal muscle index (SMI) on early functional…